Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

308 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria.
Barbhaiya M, Zuily S, Naden R, Hendry A, Manneville F, Amigo MC, Amoura Z, Andrade D, Andreoli L, Artim-Esen B, Atsumi T, Avcin T, Belmont HM, Bertolaccini ML, Branch DW, Carvalheiras G, Casini A, Cervera R, Cohen H, Costedoat-Chalumeau N, Crowther M, de Jesus G, Delluc A, Desai S, De Sancho M, Devreese KM, Diz-Kucukkaya R, Duarte-Garcia A, Frances C, Garcia D, Gris JC, Jordan N, Leaf RK, Kello N, Knight JS, Laskin C, Lee AI, Legault K, Levine SR, Levy RA, Limper M, Lockshin MD, Mayer-Pickel K, Musial J, Meroni PL, Orsolini G, Ortel TL, Pengo V, Petri M, Pons-Estel G, Gomez-Puerta JA, Raimboug Q, Roubey R, Sanna G, Seshan SV, Sciascia S, Tektonidou MG, Tincani A, Wahl D, Willis R, Yelnik C, Zuily C, Guillemin F, Costenbader K, Erkan D; ACR/EULAR APS Classification Criteria Collaborators. Barbhaiya M, et al. Among authors: ortel tl. Arthritis Rheumatol. 2023 Oct;75(10):1687-1702. doi: 10.1002/art.42624. Epub 2023 Aug 28. Arthritis Rheumatol. 2023. PMID: 37635643 Free article.
Anti-Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody-Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Clinical Database and Repository.
Zuo Y, Navaz S, Tsodikov A, Kmetova K, Kluge L, Ambati A, Hoy CK, Yalavarthi S, de Andrade D, Tektonidou MG, Sciascia S, Pengo V, Ruiz-Irastorza G, Belmont HM, Gerosa M, Fortin PR, de Jesus GR, Branch DW, Andreoli L, Rodriguez-Almaraz E, Petri M, Cervera R, Willis R, Karp DR, Li QZ, Cohen H, Bertolaccini ML, Erkan D, Knight JS; Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking. Zuo Y, et al. Arthritis Rheumatol. 2023 Aug;75(8):1407-1414. doi: 10.1002/art.42489. Epub 2023 May 18. Arthritis Rheumatol. 2023. PMID: 36862141 Free PMC article.
Lessons Learned from National Heart, Lung, and Blood Institute Covid-19 Clinical Trials.
Thomas SM, Harrington RA, Yancy CW, Nugent D, Erzurum S, Bernard GR, Cushman M, Hochman JS, Ridker PM, Ortel TL, Collins SP, Callaway CW, Nolen TL, Womack KN, Brown SM, Gelijns A, Geraci M, Ginde AA, Key NS, Krishnan JA, LaVange L, Wisniewski SR, Berdan L, Punturieri A, Goff DC, Patterson AP. Thomas SM, et al. Among authors: ortel tl. NEJM Evid. 2024 Nov;3(11):EVIDctcs2300291. doi: 10.1056/EVIDctcs2300291. Epub 2024 Oct 22. NEJM Evid. 2024. PMID: 39437132 Free PMC article.
Racial Disparities in the Incidence and Risk Factors for Major Bleeding during Extended Anticoagulant Therapy for Venous Thromboembolism.
Omar D, Kovacs MJ, Lazo-Langner A, Anderson DR, Kahn SR, Castellucci LA, Schmidt J, Elias A, Righini M, Ortel TL, Huisman MV, Carrier M, Cénat JM, Mallick R, Rodger MA, Le Gal G, Wells PS, Xu Y. Omar D, et al. Among authors: ortel tl. J Thromb Haemost. 2025 Aug 4:S1538-7836(25)00489-1. doi: 10.1016/j.jtha.2025.07.026. Online ahead of print. J Thromb Haemost. 2025. PMID: 40769433 Free article.
Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-C Report: Assessment of Patient Scenarios (Derivation Cohort) and Refinement of Definitions.
Barbhaiya M, Zuily S, Jannat-Khah D, Amigo MC, Andrade D, Avcin T, Bertolaccini ML, Branch DW, Costedoat-Chalumeau N, de Jesús GR, Devreese KMJ, Garcia D, Gomez Puerta JA, Guillemin F, Levine SR, Levy RA, Lockshin MD, Ortel TL, Petri M, Sanna G, Sciascia S, Seshan SV, Tektonidou M, Wahl D, Willis R, Yelnik C, Hendry A, Naden R, Costenbader KH, Erkan D; New APS Classification Criteria Collaborators. Barbhaiya M, et al. Among authors: ortel tl. Arthritis Care Res (Hoboken). 2025 Jul 7. doi: 10.1002/acr.25599. Online ahead of print. Arthritis Care Res (Hoboken). 2025. PMID: 40621809
An update on laboratory detection and interpretation of antiphospholipid antibodies for diagnosis of antiphospholipid syndrome: guidance from the ISTH-SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies: reply.
Devreese KMJ, Bertolaccini ML, Branch DW, de Laat B, Erkan D, Favaloro EJ, Pengo V, Ortel TL, Wahl D, Cohen H. Devreese KMJ, et al. Among authors: ortel tl. J Thromb Haemost. 2025 May;23(5):1732-1734. doi: 10.1016/j.jtha.2025.02.018. J Thromb Haemost. 2025. PMID: 40306820 No abstract available.
Duration of primary/secondary treatment to prevent recurrent venous thromboembolism: a systematic review and meta-analysis.
Li A, Khatib R, Lopes LC, Aloweni F, Lu L, He Q, Wu J, Zhang P, Tang Y, Pavalagantharajah S, Sekercioglu N, Cuello Garcia CA, Koujanian S, Agarwal A, Kennedy SA, Neumann I, Schulman S, Wiercioch W, Rada G, Peseski AM, Ortel TL, Zhang YQ. Li A, et al. Among authors: ortel tl. Blood Adv. 2025 Apr 8;9(7):1742-1761. doi: 10.1182/bloodadvances.2024015371. Blood Adv. 2025. PMID: 40198201 Free PMC article.
308 results